Connect your AI

Opko Health OPK Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Quest DiagnosticsDGX

$0-100%

AbbottABT

$19.86B+1,985,900%

Amneal Pharmaceuticals, Inc.AMRX

$134.67M—

AmgenAMGN

$3.96B—

AbbVieABBV

$7.99B+100%

Johnson & JohnsonJNJ

$0-100%

Other financials

Income statement

Revenue$124.2M-17.2%

Gross profit$45.8M+7.4%

Operating income-$51.0M+24.0%

Net income-$54.8M+18.9%

EPS (diluted)-$0.07+30.0%

Balance sheet

Cash & equivalents$40.6M-62.5%

Total debt$52.8M-4.2%

Total equity$1.2B-8.2%

Total assets$1.9B-12.8%

Cash flow

Operating cash flow-$19.3M+44.1%

CapEx$1.8M-42.6%

Free cash flow-$21.1M+44.0%

Valuation

Market cap$1.13B-22.4%

P/S1.9×-0.2×

Profitability

Gross margin36%+4.2pp

Operating margin-17.4%-5.6pp

Net margin-36.6%-44.8pp

FCF margin-30%+0.1pp

Returns & leverage

Return on equity-16.9%-21.7pp

Debt / equity0×0.0×

Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Opko Health's debt issuance proceeds?: Opko Health (OPK) reported debt issuance proceeds of $8.49M in Q1 2026.
How has Opko Health's debt issuance proceeds changed year-over-year?: Opko Health's debt issuance proceeds increased by 51.3% year-over-year, from $5.61M to $8.49M.
What is the long-term trend for Opko Health's debt issuance proceeds?: Over 3 years (2021 to 2025), Opko Health's debt issuance proceeds has grown at a -73.0% compound annual growth rate (CAGR), from $1.68B to $33.03M.
What does debt issuance proceeds mean?: Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.